ホーム>>Analytical Standards>>3,4-Dimethylmethcathinone metabolite (hydrochloride) ((±)-Ephedrine stereochemistry)

3,4-Dimethylmethcathinone metabolite (hydrochloride) ((±)-Ephedrine stereochemistry) (Synonyms: 3,4DMMC metabolite)

カタログ番号GC42209

3,4-DMMC(塩酸塩)は、アンフェタミン、カチノン、フェネチルアミンの特徴を併せ持つ潜在的なデザイナードラッグです。

Products are for research use only. Not for human use. We do not sell to patients.

3,4-Dimethylmethcathinone metabolite (hydrochloride) ((±)-Ephedrine stereochemistry) 化学構造

Cas No.: 4865-61-6

サイズ 価格 在庫数 個数
500μg
$128.00
在庫あり
1mg
$194.00
在庫あり
5mg
$899.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

3,4-DMMC (hydrochloride) is a potential designer drug with combined features of amphetamines, cathinones, and phenethylamines. It is structurally related to 4-methylmethcathinone, a psychoactive compound that has been identified in products sold as bath salts and plant food. This metabolite of 3,4-DMMC features conversion of the β-keto group to β-hydroxy and is an enantiomeric mixture of the R,S and S,R orientations at carbons one and two, as in ephedrine. The physiological and toxicological properties of this compound have not been elucidated. This product is intended for research and forensic applications.

レビュー

Review for 3,4-Dimethylmethcathinone metabolite (hydrochloride) ((±)-Ephedrine stereochemistry)

Average Rating: 5 ★★★★★ (Based on Reviews and 23 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 3,4-Dimethylmethcathinone metabolite (hydrochloride) ((±)-Ephedrine stereochemistry)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.